Descriptor English: | Levetiracetam | ||||||
Descriptor Spanish: |
Levetiracetam
| ||||||
Descriptor Portuguese: | Levetiracetam | ||||||
Descriptor French: | Lévétiracétam | ||||||
Entry term(s): |
Etiracetam Etiracetam, (R)- Etiracetam, R isomer Etiracetam, R-isomer Etiracetam, S isomer Etiracetam, S-isomer Keppra R-isomer Etiracetam S-isomer Etiracetam UCB 6474 UCB-6474 UCB6474 Ucb L059 Ucb L060 Ucb-L059 Ucb-L060 UcbL060 alpha ethyl 2 oxo 1 Pyrrolidineacetamide alpha-ethyl-2-oxo-1-Pyrrolidineacetamide |
||||||
Tree number(s): |
D02.065.064.432 D02.241.081.018.110.463 D03.383.773.812.362 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000077287 | ||||||
Scope note: | A pyrrolidinone and acetamide derivative that is used primarily for the treatment of SEIZURES and some movement disorders, and as a nootropic agent. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Anticonvulsants Nootropic Agents |
||||||
Registry Number: | 44YRR34555 | ||||||
CAS Type 1 Name: | 1-Pyrrolidineacetamide, alpha-ethyl-2-oxo-, (alphaS)- | ||||||
Public MeSH Note: | 2019; see ETIRACETAM 1980-2018; LEVETIRACETAM was indexed under PIRACETAM/analogs & derivatives 1980-2018 |
||||||
History Note: | 2019 (1980) |
||||||
DeCS ID: | 57588 | ||||||
Unique ID: | D000077287 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2019/01/01 | ||||||
Date of Entry: | 2018/07/09 | ||||||
Revision Date: | 2018/07/03 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Levetiracetam
- Preferred
Ucb L059
- Narrower
UCB 6474
- Narrower
Etiracetam, R-isomer
- Narrower
Keppra
- Narrower
Etiracetam
- Narrower
Ucb L060
- Narrower
Concept UI |
M0374035 |
Scope note | A pyrrolidinone and acetamide derivative that is used primarily for the treatment of SEIZURES and some movement disorders, and as a nootropic agent. |
Preferred term | Levetiracetam |
Entry term(s) |
Etiracetam, S isomer Etiracetam, S-isomer S-isomer Etiracetam |
Concept UI |
M0086085 |
Preferred term | Ucb L059 |
Entry term(s) |
Ucb-L059 |
Concept UI |
M0086081 |
Preferred term | UCB 6474 |
Entry term(s) |
UCB-6474 UCB6474 |
Concept UI |
M0316684 |
Preferred term | Etiracetam, R-isomer |
Entry term(s) |
Etiracetam, (R)- Etiracetam, R isomer R-isomer Etiracetam |
Concept UI |
M0398712 |
Preferred term | Keppra |
Concept UI |
M0086089 |
Preferred term | Etiracetam |
Entry term(s) |
alpha ethyl 2 oxo 1 Pyrrolidineacetamide alpha-ethyl-2-oxo-1-Pyrrolidineacetamide |
Concept UI |
M0086086 |
Preferred term | Ucb L060 |
Entry term(s) |
Ucb-L060 UcbL060 |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey